GH-axis peptide research
Tesamorelin
Growth-hormone-releasing hormone (GHRH) analog
Coming soon· check back for availability
| Form | Lyophilized powder |
|---|---|
| Purity | Coming soon |
| Storage | −20 °C, protect from light |
| Use | Laboratory research only |
Coming soon
Ask about availability
For laboratory research use only. Not for human or veterinary use. Not a drug, supplement, or cosmetic. No dosing, administration, or use guidance is provided.
About this compound
Identity & research context
Tesamorelin is a stabilized synthetic analog of growth-hormone-releasing hormone (GHRH). In preclinical and in-vitro model systems it has been studied as a GHRH-receptor agonist and as a tool compound for investigating the growth-hormone / IGF-1 signaling axis and associated metabolic pathways.
Key research points
- GHRH-receptor agonism (in-vitro)
- GH / IGF-1 axis signaling (animal models)
- Visceral-adipose-tissue research models (preclinical)
- Metabolic-marker research (exploratory)
Published preclinical literature available on request. Specs and certificate details will be listed when this compound goes live.
For research purposes only. Not FDA approved. Information shown is sourced from published peer-reviewed literature for educational reference only — not medical advice or product claims. Read the full disclaimer.
Also in the catalog
View all